Bayer

News

Bayer launches digital AI platform for radiology specialists

Bayer has stepped up the digital capabilities of its radiology business with the launch of artificial intelligence-based apps for X-ray, MRI and CT imaging.

News

Bayer bails on $670m CAR-T partnership with Atara

In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for mesothelioma after a patient death.

News

Chasing rivals, Bayer files Nubeqa for new prostate cancer u...

Bayer has filed for approval to extend the use of its prostate cancer therapy Nubeqa as it tries to achieve labelling parity with rival drugs from Pfizer/Astellas and Johnson & Jonson,

News

Mature Woman Experiencing Hot Flush From Menopause

Astellas' eyes filings for menopause drug fezolinetant after...

Astellas looks to be in pole position to bring a new non-hormonal therapy for symptoms of menopause to market, after its candidate fezolinetant cleared a phase 3 safety study.

News

Ardelyx’s-ambition-to-revolutionise-kidney-treatment

EU clears Bayer's chronic kidney disease drug Kerendia

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival th

News

Bayer triples sales forecast for prostate cancer drug Nubeqa

Bayer now says it expects to make €3 billion in sales for its prostate cancer treatment Nubeqa, up from an earlier estimate of €1 billion, after reviewing new data for the drug in metastati

Bayer launches digital AI platform for radiology specialists

Bayer bails on $670m CAR-T partnership with Atara

Chasing rivals, Bayer files Nubeqa for new prostate cancer u...

Astellas' eyes filings for menopause drug fezolinetant after...

EU clears Bayer's chronic kidney disease drug Kerendia

Bayer triples sales forecast for prostate cancer drug Nubeqa

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

Bayer

Editor's Picks